Nephrocare Health IPO Opens Tomorrow, December 10: How to Apply and More

Nephrocare Health will open its initial public offering (IPO) for subscription on December 10, 2025, and close on December 12, 2025. The company plans to raise ₹871.05 crore through a combination of fresh issue and offer for sale.

The IPO price band has been fixed at ₹438 to ₹460 per share. Investors can bid for shares within this range during the subscription window.

How to Apply for Nephrocare Health IPO Online?

To apply for an IPO online, log in through your broker or bank, select the IPO, enter your bid and UPI/Demat details, and approve the mandate; the amount is only blocked until allotment.

Method 1: Through Your Stock Broker (UPI)

• Log in to your trading app or broker platform.
• Go to the IPO/Bids section.
• Select Nephrocare Health IPO.
• Enter UPI ID, lot quantity, and bid price (or cut-off).
• Submit the application.
• Approve the UPI mandate in your payment app.

Method 2: Through Bank Net Banking (ASBA)

• Log in to your bank’s net banking portal.
• Open the IPO or ASBA Services section.
• Select Nephrocare Health IPO.
• Enter Demat details, bid quantity, and price.
• Submit the application.
• Funds remain blocked until allotment.

IPO Structure and Fund Allocation

The IPO consists of a fresh issue of 0.77 crore shares aggregating to ₹353.40 crore and an offer for sale of 1.13 crore shares worth ₹517.64 crore. From the fresh issue proceeds, ₹129.1 crore will be allocated for setting up new dialysis clinics across India.

Another ₹136 crore will be used for debt repayment, reducing the company’s financial liabilities. The remaining funds will go toward general corporate purposes, supporting operational and strategic needs.

Operations and Market Presence

NephroPlus, founded in 2009, operates one of India’s largest dialysis networks. As of March 31, the company managed 447 clinics in 269 cities across 21 states and four Union Territories.

It serves approximately 33,000 patients annually and holds a revenue market share of over 50% in the organised dialysis segment by treatments. Its services include haemodialysis, home haemodialysis, hemodiafiltration, and mobile options such as dialysis on call and dialysis on wheels.

Financial Performance and Global Expansion

The company operated more than 5,000 dialysis machines and completed over 3.3 million treatments as of March 31. Its international presence spans the Philippines, Nepal, Uzbekistan, and Saudi Arabia, with 51 overseas clinics as of September 2025.

For FY25, NephroPlus reported revenue from operations of ₹755.8 crore. The company also posted a profit after tax of ₹67 crore, reflecting its strong financial position in the healthcare sector.

Read More: ICICI Prudential AMC Set for $1.2 Billion IPO Launch.

Conclusion

Nephrocare Health’s IPO aims to strengthen its domestic footprint and reduce debt while expanding dialysis services. The ₹871.05 crore issue combines fresh capital for growth and an OFS by existing investors.

With a strong presence in India and growing international operations, the company seeks to leverage its leadership in the organised dialysis segment. Market response will depend on investor appetite for healthcare-focused offerings during the subscription period.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.